Protamine stimulates platelet aggregation in vitro with activation of the fibrinogen receptor and alpha-granule release, but impairs secondary activation via ADP and thrombin receptors

References

• Jaques LB. Protamine—antagonist to heparin. Can Med Assoc J 1973;108:1291–1297.
   PubMed Web of Science ®Google Scholar
• Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SAM. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73–92. doi:https://doi.org/10.1016/j.ejcts.2008.02.024.
   PubMed Web of Science ®Google Scholar
• Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011;113:1319–1333. doi:https://doi.org/10.1213/ANE.0b013e3182354b7e.
   PubMed Web of Science ®Google Scholar
• Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995;110:46–54. doi:https://doi.org/10.1016/S0022-5223(05)80008-X.
   PubMed Web of Science ®Google Scholar
• Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 1995;110:36–45. doi:https://doi.org/10.1016/S0022-5223(05)80007-8.
   PubMed Web of Science ®Google Scholar
• Shigeta O, Kojima H, Hiramatsu Y, Jikuya T, Terada Y, Atsumi N, Sakakibara Y, Nagasawa T, Mitsui T. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;118:354–360. doi:https://doi.org/10.1016/S0022-5223(99)70227-8.
   PubMed Web of Science ®Google Scholar
• Machi J, Sigel B, Feinberg H. Protamine-induced platelet aggregation and clotting investigated by ultrasound. Haemostasis 1987;17:226–234. doi:https://doi.org/10.1159/000215748.
   PubMedGoogle Scholar
• Boer C, Meesters MI, Veerhoek D, Vonk ABA. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth 2018;120:914–927. doi:https://doi.org/10.1016/j.bja.2018.01.023.
   PubMed Web of Science ®Google Scholar
• Hofer A, Kozek-Langenecker S, Schaden E, Panholzer M, Gombotz H. Point-of-care assessment of platelet aggregation in paediatric open heart surgery. Br J Anaesth 2011;107:587–592. doi:https://doi.org/10.1093/bja/aer190.
   PubMed Web of Science ®Google Scholar
• Malm CJ, Hansson EC, Åkesson J, Andersson M, Hesse C, Shams Hakimi C, Jeppsson A. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth 2016;117:309–315. doi:https://doi.org/10.1093/bja/aew189.
   PubMed Web of Science ®Google Scholar
• Gertler R, Wiesner G, Tassani-Prell P, Braun SL, Martin K. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine? J Cardiothorac Vasc Anesth 2011;25:981–986. doi:https://doi.org/10.1053/j.jvca.2010.11.020.
   PubMed Web of Science ®Google Scholar
• Ramström S, Södergren AL, Tynngård N, Lindahl TL. Platelet function determined by flow cytometry: new perspectives? Semin Thromb Hemost 2016;42:268–281. doi:https://doi.org/10.1055/s-00000077.
   PubMed Web of Science ®Google Scholar
• Södergren AL, Ramström S. Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol. Sci Rep 2018;8:1441. doi:https://doi.org/10.1038/s41598-017-19126-8.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000;83:589–591. doi:https://doi.org/10.1055/s-0037-1613868.
   PubMed Web of Science ®Google Scholar
• Olsson A, Alfredsson J, Håkansson E, Svedjeholm R, Berglund J, Berg S. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass. Scand Cardiovasc J 2015;50:58–63. doi:https://doi.org/10.3109/14017431.2015.1099720.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;87:781–785. doi:https://doi.org/10.1097/00000539-199810000-00008.
   PubMed Web of Science ®Google Scholar
• Griffin MJ, Rinder HM, Smith BR, Tracey JB, Kriz NS, Li CK, Rinder CS. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg 2001;93:20–27. doi:https://doi.org/10.1097/00000539-200107000-00005.
   PubMed Web of Science ®Google Scholar
• Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980;3:135–158. doi:https://doi.org/10.1016/0160-5402(80)90024-8.
   PubMedGoogle Scholar
• Rubak P, Nissen PH, Kristensen SD, Hvas A-M. Investigation of platelet function and platelet disorders using flow cytometry. Platelets 2015;27:66–74. doi:https://doi.org/10.3109/09537104.2015.1032919.
   PubMed Web of Science ®Google Scholar
• Obydennyy SI, Sveshnikova AN, Ataullakhanov FI, Panteleev MA. Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation. J Thromb and Haemost 2016;14:1867–1881. doi:https://doi.org/10.1111/jth.13395.
   PubMed Web of Science ®Google Scholar
• Ortmann E, Klein AA, Sharples LD, Walsh R, Jenkins DP, Luddington RJ, Besser MW. Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry (Multiplate®) in patients undergoing cardiopulmonary bypass. Anesth Analg 2013;116:533–540. doi:https://doi.org/10.1213/ANE.0b013e31827cee88.
   PubMed Web of Science ®Google Scholar
• Hofmann B, Bushnaq H, Kraus FB, Raspé C, Simm A, Silber RE, Ludwig-Kraus B. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy. Perfusion 2013;28:412–418. doi:https://doi.org/10.1177/0267659113483800.
   PubMed Web of Science ®Google Scholar
• Ni Ainle F, Preston RJS, Jenkins PV, Nel HJ, Johnson JA, Smith OP, White B, Fallon PG, O’Donnell JS. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood 2009;114:1658–1665. doi:https://doi.org/10.1182/blood-2009-05-222109.
   PubMed Web of Science ®Google Scholar
• Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107–117. doi:https://doi.org/10.1182/blood.V82.1.107.bloodjournal821107.
   PubMed Web of Science ®Google Scholar
• Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 2002;74:1589–1595. doi:https://doi.org/10.1016/S0003-4975(02)04016-X.
   PubMed Web of Science ®Google Scholar
• Spiess BD, Horrow J, Kaplan JA. Transfusion medicine and coagulation disorders. In: Kaplan JA, Reich DL, Konstadt SN, editors. Kaplan’s cardiac anesthesia: the echo era. 6th ed. St. Louis: Elsevier Saunders; 2011. p. 949–991.
   Google Scholar
• Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985;64:348–361. doi:https://doi.org/10.1213/00000539-198503000-00008.
   PubMed Web of Science ®Google Scholar